Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T19:27:52.988Z.
Calculation as of: 2026-10-06T19:27:52.988Z.
Quote observation: 2026-10-06T19:25:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 08fea6a2878daf509c4a2714b7418dcfec0265989d531cb4479ebc608e1bd708
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$285.26M
EV/FCF Ratio
N/A
TTM Avg
37.98x
3Y Avg
37.98x
5Y Avg
37.98x
Market Cap
$283.24M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$281.90M
EV/FCF Ratio
N/A
TTM Avg
52.46x
3Y Avg
52.46x
5Y Avg
52.46x
Market Cap
$288.77M
EV/FCF Ratio
N/A
TTM Avg
1.69x
3Y Avg
1.69x
5Y Avg
1.69x
Market Cap
$296.58M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sagimet Biosciences Inc. (SGMT) | $286.46M | N/A | N/A | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.26M | N/A | 37.98x | 37.98x | 37.98x |
| Aurora Cannabis Inc. (ACB)vs › | $283.39M | N/A | N/A | N/A | N/A |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $283.24M | N/A | N/A | N/A | N/A |
| Standard BioTools Inc. (LAB)vs › | $282.83M | N/A | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.35M | N/A | N/A | N/A | N/A |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.90M | N/A | 52.46x | 52.46x | 52.46x |
| Indaptus Therapeutics, Inc. (INDP)vs › | $288.77M | N/A | 1.69x | 1.69x | 1.69x |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $296.58M | N/A | N/A | N/A | N/A |
| Rocket Pharmaceuticals, Inc. (RCKT)vs › | $270.25M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
